CYP2D6 Genotyping and Inhibition as Predictors of Adverse Drug Reactions in Depressive Disorders

Conclusions: We did not find that CYP2D6 phenotype could predict the occurrence of adverse drug reactions in patients with depressive disorders in this naturalistic setting. However, information about CYP2D6 genotype may still be important in antidepressant treatment for the selection of appropriate drugs, for dosing recommendations of certain medications, or when the patient is suffering from severe adverse reactions.PMID:38236047 | DOI:10.4088/JCP.23m14937
Source: Journal of Clinical Psychiatry - Category: Psychiatry Authors: Source Type: research